Galena Biopharma, Inc.

NASDAQ: GALE
$0.26
-$0.01 (-5.1%)
Closing price December 29, 2017
Source: ThinkstockStocks are challenging all-time highs, and this is a shortened week due to Thanksgiving. Investors have to start positioning their assets and portfolios for 2014. 24/7 Wall St....
Source: ThinkstockThe Wall Street firms that handle the bulk of retail accounts are always very careful about recommending stocks priced in the single digits. Typically they are fallen angels, or...
Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas from...
Source: thinkstockHere are the five biggest gaining stocks in today’s U.S. markets at closing:Imperial Holdings Inc. (NYSE: IFT) is up 40.5% at $5.59.Kingtone WirelessInfo Solution Holding Ltd....
It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is up 11.3% at 14,590, and that is a far cry from gains...
U.S. equity markets opened higher this morning on speculation — and some reports — that budget talks in the U.S. were making some progress. Asian markets clearly thought so, with most...
The stock market is up Tuesday, with the Dow Jones Industrial Average up 0.43%, the Nasdaq up 0.81%, and the S&P 500 up 0.62%. Today’s winners include a pharmaceutical company reporting a...
The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.02%, the Nasdaq down 0.54% and the S&P 500 down 0.20%. Today’s winners include a pharmaceutical company...
The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.11%, the Nasdaq down 0.37% and the S&P 500 up 0.05%. Today’s sole winner reported earnings that fell in line...
As investors brace for Wednesday’s congressional testimony from Federal Reserve Chairman Ben Bernanke, the stock market is up modestly. The Dow Jones Industrial Average is up 0.38%, the Nasdaq is...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.Amazon.com, Inc. (NASDAQ: AMZN) removed from Conviction Buy List...
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  The 2012 annual meeting of the American...
Biotech firm Galena Biopharma Inc. (NASDAQ: GALE) this morning priced a secondary offering of 8.5 million shares at $1.50/share, a discount of nearly 20% to last night’s closing price of $1.87. The...